 | • レポートコード：GIR-107A12203 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、123ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、サイトメガロウイルス（HHV-5）感染症治療薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。サイトメガロウイルス（HHV-5）感染症治療薬の種類別市場規模（経口薬、注射）、用途別市場規模（病院、クリニック、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・サイトメガロウイルス（HHV-5）感染症治療薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：3-V Biosciences, Inc.、AIMM Therapeutics、AlphaVax、Altor BioScience、Applied Immune、Astellas、BioApex、Bionor Pharma、Biotest、Pfizer、Cell Medica、Chimerix、GSK、Hookipa Biotech、Humabs BioMed、Inagen、Kadmon Corporation、Lead Discovery Center、Merck、Novartis ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：経口薬、注射 ・用途別分析2016年-2026年：病院、クリニック、その他 ・サイトメガロウイルス（HHV-5）感染症治療薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・サイトメガロウイルス（HHV-5）感染症治療薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・サイトメガロウイルス（HHV-5）感染症治療薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・サイトメガロウイルス（HHV-5）感染症治療薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・サイトメガロウイルス（HHV-5）感染症治療薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Cytomegalovirus（HHV-5）Infection Therapeutic Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Cytomegalovirus（HHV-5）Infection Therapeutic Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Oral Medication
Injection
Market segment by Application, can be divided into
Hospital
Clinic
Other
Market segment by players, this report covers
3-V Biosciences, Inc.
AIMM Therapeutics
AlphaVax
Altor BioScience
Applied Immune
Astellas
BioApex
Bionor Pharma
Biotest
Pfizer
Cell Medica
Chimerix
GSK
Hookipa Biotech
Humabs BioMed
Inagen
Kadmon Corporation
Lead Discovery Center
Merck
Novartis
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Cytomegalovirus（HHV-5）Infection Therapeutic Drugs
1.2 Classification of Cytomegalovirus（HHV-5）Infection Therapeutic Drugs by Type
1.2.1 Overview: Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue Market Share by Type in 2020
1.2.3 Oral Medication
1.2.4 Injection
1.3 Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market by Application
1.3.1 Overview: Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size & Forecast
1.5 Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size and Forecast by Region
1.5.1 Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Region, (2016-2021)
1.5.3 North America Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size and Prospect (2016-2026)
1.5.4 Europe Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size and Prospect (2016-2026)
1.5.6 South America Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Drivers
1.6.2 Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Restraints
1.6.3 Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Trends Analysis
2 Company Profiles
2.1 3-V Biosciences, Inc.
2.1.1 3-V Biosciences, Inc. Details
2.1.2 3-V Biosciences, Inc. Major Business
2.1.3 3-V Biosciences, Inc. Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Product and Solutions
2.1.4 3-V Biosciences, Inc. Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 3-V Biosciences, Inc. Recent Developments and Future Plans
2.2 AIMM Therapeutics
2.2.1 AIMM Therapeutics Details
2.2.2 AIMM Therapeutics Major Business
2.2.3 AIMM Therapeutics Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Product and Solutions
2.2.4 AIMM Therapeutics Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 AIMM Therapeutics Recent Developments and Future Plans
2.3 AlphaVax
2.3.1 AlphaVax Details
2.3.2 AlphaVax Major Business
2.3.3 AlphaVax Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Product and Solutions
2.3.4 AlphaVax Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 AlphaVax Recent Developments and Future Plans
2.4 Altor BioScience
2.4.1 Altor BioScience Details
2.4.2 Altor BioScience Major Business
2.4.3 Altor BioScience Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Product and Solutions
2.4.4 Altor BioScience Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Altor BioScience Recent Developments and Future Plans
2.5 Applied Immune
2.5.1 Applied Immune Details
2.5.2 Applied Immune Major Business
2.5.3 Applied Immune Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Product and Solutions
2.5.4 Applied Immune Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Applied Immune Recent Developments and Future Plans
2.6 Astellas
2.6.1 Astellas Details
2.6.2 Astellas Major Business
2.6.3 Astellas Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Product and Solutions
2.6.4 Astellas Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Astellas Recent Developments and Future Plans
2.7 BioApex
2.7.1 BioApex Details
2.7.2 BioApex Major Business
2.7.3 BioApex Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Product and Solutions
2.7.4 BioApex Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 BioApex Recent Developments and Future Plans
2.8 Bionor Pharma
2.8.1 Bionor Pharma Details
2.8.2 Bionor Pharma Major Business
2.8.3 Bionor Pharma Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Product and Solutions
2.8.4 Bionor Pharma Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Bionor Pharma Recent Developments and Future Plans
2.9 Biotest
2.9.1 Biotest Details
2.9.2 Biotest Major Business
2.9.3 Biotest Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Product and Solutions
2.9.4 Biotest Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Biotest Recent Developments and Future Plans
2.10 Pfizer
2.10.1 Pfizer Details
2.10.2 Pfizer Major Business
2.10.3 Pfizer Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Product and Solutions
2.10.4 Pfizer Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Pfizer Recent Developments and Future Plans
2.11 Cell Medica
2.11.1 Cell Medica Details
2.11.2 Cell Medica Major Business
2.11.3 Cell Medica Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Product and Solutions
2.11.4 Cell Medica Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Cell Medica Recent Developments and Future Plans
2.12 Chimerix
2.12.1 Chimerix Details
2.12.2 Chimerix Major Business
2.12.3 Chimerix Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Product and Solutions
2.12.4 Chimerix Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Chimerix Recent Developments and Future Plans
2.13 GSK
2.13.1 GSK Details
2.13.2 GSK Major Business
2.13.3 GSK Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Product and Solutions
2.13.4 GSK Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 GSK Recent Developments and Future Plans
2.14 Hookipa Biotech
2.14.1 Hookipa Biotech Details
2.14.2 Hookipa Biotech Major Business
2.14.3 Hookipa Biotech Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Product and Solutions
2.14.4 Hookipa Biotech Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Hookipa Biotech Recent Developments and Future Plans
2.15 Humabs BioMed
2.15.1 Humabs BioMed Details
2.15.2 Humabs BioMed Major Business
2.15.3 Humabs BioMed Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Product and Solutions
2.15.4 Humabs BioMed Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 Humabs BioMed Recent Developments and Future Plans
2.16 Inagen
2.16.1 Inagen Details
2.16.2 Inagen Major Business
2.16.3 Inagen Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Product and Solutions
2.16.4 Inagen Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.16.5 Inagen Recent Developments and Future Plans
2.17 Kadmon Corporation
2.17.1 Kadmon Corporation Details
2.17.2 Kadmon Corporation Major Business
2.17.3 Kadmon Corporation Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Product and Solutions
2.17.4 Kadmon Corporation Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.17.5 Kadmon Corporation Recent Developments and Future Plans
2.18 Lead Discovery Center
2.18.1 Lead Discovery Center Details
2.18.2 Lead Discovery Center Major Business
2.18.3 Lead Discovery Center Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Product and Solutions
2.18.4 Lead Discovery Center Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.18.5 Lead Discovery Center Recent Developments and Future Plans
2.19 Merck
2.19.1 Merck Details
2.19.2 Merck Major Business
2.19.3 Merck Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Product and Solutions
2.19.4 Merck Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.19.5 Merck Recent Developments and Future Plans
2.20 Novartis
2.20.1 Novartis Details
2.20.2 Novartis Major Business
2.20.3 Novartis Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Product and Solutions
2.20.4 Novartis Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.20.5 Novartis Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Players Market Share
3.2.2 Top 10 Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Players Market Share
3.2.3 Market Competition Trend
3.3 Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue and Market Share by Type (2016-2021)
4.2 Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue Market Share by Application (2016-2021)
5.2 Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue by Type (2016-2026)
6.2 North America Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue by Application (2016-2026)
6.3 North America Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Country
6.3.1 North America Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue by Country (2016-2026)
6.3.2 United States Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size and Forecast (2016-2026)
6.3.3 Canada Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size and Forecast (2016-2026)
6.3.4 Mexico Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue by Type (2016-2026)
7.2 Europe Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue by Application (2016-2026)
7.3 Europe Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Country
7.3.1 Europe Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue by Country (2016-2026)
7.3.2 Germany Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size and Forecast (2016-2026)
7.3.3 France Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size and Forecast (2016-2026)
7.3.5 Russia Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size and Forecast (2016-2026)
7.3.6 Italy Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue by Type (2016-2026)
8.2 Asia-Pacific Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue by Application (2016-2026)
8.3 Asia-Pacific Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Region
8.3.1 Asia-Pacific Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue by Region (2016-2026)
8.3.2 China Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size and Forecast (2016-2026)
8.3.3 Japan Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size and Forecast (2016-2026)
8.3.4 South Korea Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size and Forecast (2016-2026)
8.3.5 India Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size and Forecast (2016-2026)
8.3.7 Australia Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue by Type (2016-2026)
9.2 South America Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue by Application (2016-2026)
9.3 South America Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Country
9.3.1 South America Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue by Country (2016-2026)
9.3.2 Brazil Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size and Forecast (2016-2026)
9.3.3 Argentina Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue by Type (2016-2026)
10.2 Middle East & Africa Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue by Application (2016-2026)
10.3 Middle East & Africa Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size by Country
10.3.1 Middle East & Africa Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue by Country (2016-2026)
10.3.2 Turkey Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size and Forecast (2016-2026)
10.3.4 UAE Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue (USD Million) by Region (2016-2021)
Table 5. Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue Market Share by Region (2021-2026)
Table 6. 3-V Biosciences, Inc. Corporate Information, Head Office, and Major Competitors
Table 7. 3-V Biosciences, Inc. Major Business
Table 8. 3-V Biosciences, Inc. Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Product and Solutions
Table 9. 3-V Biosciences, Inc. Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. AIMM Therapeutics Corporate Information, Head Office, and Major Competitors
Table 11. AIMM Therapeutics Major Business
Table 12. AIMM Therapeutics Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Product and Solutions
Table 13. AIMM Therapeutics Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. AlphaVax Corporate Information, Head Office, and Major Competitors
Table 15. AlphaVax Major Business
Table 16. AlphaVax Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Product and Solutions
Table 17. AlphaVax Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Altor BioScience Corporate Information, Head Office, and Major Competitors
Table 19. Altor BioScience Major Business
Table 20. Altor BioScience Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Product and Solutions
Table 21. Altor BioScience Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Applied Immune Corporate Information, Head Office, and Major Competitors
Table 23. Applied Immune Major Business
Table 24. Applied Immune Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Product and Solutions
Table 25. Applied Immune Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Astellas Corporate Information, Head Office, and Major Competitors
Table 27. Astellas Major Business
Table 28. Astellas Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Product and Solutions
Table 29. Astellas Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. BioApex Corporate Information, Head Office, and Major Competitors
Table 31. BioApex Major Business
Table 32. BioApex Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Product and Solutions
Table 33. BioApex Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Bionor Pharma Corporate Information, Head Office, and Major Competitors
Table 35. Bionor Pharma Major Business
Table 36. Bionor Pharma Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Product and Solutions
Table 37. Bionor Pharma Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Biotest Corporate Information, Head Office, and Major Competitors
Table 39. Biotest Major Business
Table 40. Biotest Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Product and Solutions
Table 41. Biotest Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Pfizer Corporate Information, Head Office, and Major Competitors
Table 43. Pfizer Major Business
Table 44. Pfizer Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Product and Solutions
Table 45. Pfizer Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Cell Medica Corporate Information, Head Office, and Major Competitors
Table 47. Cell Medica Major Business
Table 48. Cell Medica Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Product and Solutions
Table 49. Cell Medica Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Chimerix Corporate Information, Head Office, and Major Competitors
Table 51. Chimerix Major Business
Table 52. Chimerix Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Product and Solutions
Table 53. Chimerix Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. GSK Corporate Information, Head Office, and Major Competitors
Table 55. GSK Major Business
Table 56. GSK Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Product and Solutions
Table 57. GSK Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Hookipa Biotech Corporate Information, Head Office, and Major Competitors
Table 59. Hookipa Biotech Major Business
Table 60. Hookipa Biotech Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Product and Solutions
Table 61. Hookipa Biotech Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Humabs BioMed Corporate Information, Head Office, and Major Competitors
Table 63. Humabs BioMed Major Business
Table 64. Humabs BioMed Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Product and Solutions
Table 65. Humabs BioMed Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. Inagen Corporate Information, Head Office, and Major Competitors
Table 67. Inagen Major Business
Table 68. Inagen Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Product and Solutions
Table 69. Inagen Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 70. Kadmon Corporation Corporate Information, Head Office, and Major Competitors
Table 71. Kadmon Corporation Major Business
Table 72. Kadmon Corporation Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Product and Solutions
Table 73. Kadmon Corporation Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 74. Lead Discovery Center Corporate Information, Head Office, and Major Competitors
Table 75. Lead Discovery Center Major Business
Table 76. Lead Discovery Center Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Product and Solutions
Table 77. Lead Discovery Center Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 78. Merck Corporate Information, Head Office, and Major Competitors
Table 79. Merck Major Business
Table 80. Merck Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Product and Solutions
Table 81. Merck Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 82. Novartis Corporate Information, Head Office, and Major Competitors
Table 83. Novartis Major Business
Table 84. Novartis Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Product and Solutions
Table 85. Novartis Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 86. Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue (USD Million) by Players (2019-2021)
Table 87. Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue Share by Players (2019-2021)
Table 88. Breakdown of Cytomegalovirus（HHV-5）Infection Therapeutic Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 89. Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Players Head Office, Products and Services Provided
Table 90. Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Mergers & Acquisitions in the Past Five Years
Table 91. Cytomegalovirus（HHV-5）Infection Therapeutic Drugs New Entrants and Expansion Plans
Table 92. Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue (USD Million) by Type (2016-2021)
Table 93. Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue Share by Type (2016-2021)
Table 94. Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue Forecast by Type (2021-2026)
Table 95. Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue by Application (2016-2021)
Table 96. Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue Forecast by Application (2021-2026)
Table 97. North America Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue by Type (2016-2021) & (USD Million)
Table 98. North America Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue by Type (2021-2026) & (USD Million)
Table 99. North America Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue by Application (2016-2021) & (USD Million)
Table 100. North America Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue by Application (2021-2026) & (USD Million)
Table 101. North America Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue by Country (2016-2021) & (USD Million)
Table 102. North America Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue by Country (2021-2026) & (USD Million)
Table 103. Europe Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue by Type (2016-2021) & (USD Million)
Table 104. Europe Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue by Type (2021-2026) & (USD Million)
Table 105. Europe Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue by Application (2016-2021) & (USD Million)
Table 106. Europe Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue by Application (2021-2026) & (USD Million)
Table 107. Europe Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue by Country (2016-2021) & (USD Million)
Table 108. Europe Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue by Country (2021-2026) & (USD Million)
Table 109. Asia-Pacific Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue by Type (2016-2021) & (USD Million)
Table 110. Asia-Pacific Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue by Type (2021-2026) & (USD Million)
Table 111. Asia-Pacific Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue by Application (2016-2021) & (USD Million)
Table 112. Asia-Pacific Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue by Application (2021-2026) & (USD Million)
Table 113. Asia-Pacific Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue by Region (2016-2021) & (USD Million)
Table 114. Asia-Pacific Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue by Region (2021-2026) & (USD Million)
Table 115. South America Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue by Type (2016-2021) & (USD Million)
Table 116. South America Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue by Type (2021-2026) & (USD Million)
Table 117. South America Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue by Application (2016-2021) & (USD Million)
Table 118. South America Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue by Application (2021-2026) & (USD Million)
Table 119. South America Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue by Country (2016-2021) & (USD Million)
Table 120. South America Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue by Country (2021-2026) & (USD Million)
Table 121. Middle East & Africa Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue by Type (2016-2021) & (USD Million)
Table 122. Middle East & Africa Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue by Type (2021-2026) & (USD Million)
Table 123. Middle East & Africa Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue by Application (2016-2021) & (USD Million)
Table 124. Middle East & Africa Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue by Application (2021-2026) & (USD Million)
Table 125. Middle East & Africa Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue by Country (2016-2021) & (USD Million)
Table 126. Middle East & Africa Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Picture
Figure 2. Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue Market Share by Type in 2020
Figure 3. Oral Medication
Figure 4. Injection
Figure 5. Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue Market Share by Application in 2020
Figure 6. Hospital Picture
Figure 7. Clinic Picture
Figure 8. Other Picture
Figure 9. Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 10. Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue and Forecast (2016-2026) & (USD Million)
Figure 11. Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue Market Share by Region (2016-2026)
Figure 12. Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue Market Share by Region in 2020
Figure 13. North America Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Europe Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Asia-Pacific Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. South America Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Middle East and Africa Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Drivers
Figure 19. Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Restraints
Figure 20. Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Trends
Figure 21. 3-V Biosciences, Inc. Recent Developments and Future Plans
Figure 22. AIMM Therapeutics Recent Developments and Future Plans
Figure 23. AlphaVax Recent Developments and Future Plans
Figure 24. Altor BioScience Recent Developments and Future Plans
Figure 25. Applied Immune Recent Developments and Future Plans
Figure 26. Astellas Recent Developments and Future Plans
Figure 27. BioApex Recent Developments and Future Plans
Figure 28. Bionor Pharma Recent Developments and Future Plans
Figure 29. Biotest Recent Developments and Future Plans
Figure 30. Pfizer Recent Developments and Future Plans
Figure 31. Cell Medica Recent Developments and Future Plans
Figure 32. Chimerix Recent Developments and Future Plans
Figure 33. GSK Recent Developments and Future Plans
Figure 34. Hookipa Biotech Recent Developments and Future Plans
Figure 35. Humabs BioMed Recent Developments and Future Plans
Figure 36. Inagen Recent Developments and Future Plans
Figure 37. Kadmon Corporation Recent Developments and Future Plans
Figure 38. Lead Discovery Center Recent Developments and Future Plans
Figure 39. Merck Recent Developments and Future Plans
Figure 40. Novartis Recent Developments and Future Plans
Figure 41. Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue Share by Players in 2020
Figure 42. Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 43. Global Top 3 Players Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue Market Share in 2020
Figure 44. Global Top 10 Players Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue Market Share in 2020
Figure 45. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 46. Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue Share by Type in 2020
Figure 47. Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Share Forecast by Type (2021-2026)
Figure 48. Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue Share by Application in 2020
Figure 49. Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market Share Forecast by Application (2021-2026)
Figure 50. North America Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Sales Market Share by Type (2016-2026)
Figure 51. North America Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Sales Market Share by Application (2016-2026)
Figure 52. North America Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue Market Share by Country (2016-2026)
Figure 53. United States Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Canada Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Mexico Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Europe Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Sales Market Share by Type (2016-2026)
Figure 57. Europe Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Sales Market Share by Application (2016-2026)
Figure 58. Europe Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue Market Share by Country (2016-2026)
Figure 59. Germany Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. France Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. United Kingdom Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Russia Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Italy Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Asia-Pacific Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Sales Market Share by Type (2016-2026)
Figure 65. Asia-Pacific Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Sales Market Share by Application (2016-2026)
Figure 66. Asia-Pacific Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue Market Share by Region (2016-2026)
Figure 67. China Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Japan Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. South Korea Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. India Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Southeast Asia Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Australia Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. South America Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Sales Market Share by Type (2016-2026)
Figure 74. South America Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Sales Market Share by Application (2016-2026)
Figure 75. South America Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue Market Share by Country (2016-2026)
Figure 76. Brazil Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Argentina Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Middle East and Africa Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Sales Market Share by Type (2016-2026)
Figure 79. Middle East and Africa Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Sales Market Share by Application (2016-2026)
Figure 80. Middle East and Africa Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue Market Share by Country (2016-2026)
Figure 81. Turkey Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 82. Saudi Arabia Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 83. UAE Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 84. Methodology
Figure 85. Research Process and Data Source
サイトメガロウイルス（HHV-5）感染症治療薬の世界市場 2019年版：種類別（経口薬、注射）、用途別（病院、診療所、その他） Description Scope of the Report: The global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in f…- 世界のサイトメガロウイルス病治療市場予測（～2024年）：企業別、地域別、種類・用途別 Cytomegalovirus disease (CMV) is a viral infection that can affect one part of the body, such as the eyes, or it can spread throughout the body. Scope of the Report: The global Cytomegalovirus Disease Treatments market is valued at xx million USD in 2018 and is expected to reach xx million USD by th…
- 世界のグラム陽性菌感染症薬市場予測（～2024年）：企業別、地域別、種類・用途別 Gram-positive bacteria are those that are stained dark blue or violet by Gram staining. They are a major class of bacteria that cause various infections in humans. Scope of the Report: The global Gram-positive Bacterial Infection Drugs market is valued at xx million USD in 2018 and is expected to re…
- 世界の眼感染症薬市場予測（～2024年）：メーカー別、地域別、種類・用途別 Scope of the Report: The worldwide market for Eye Infection Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Eye Infection Drugs…
- 世界の腸内細菌科感染症薬市場 2021：企業別、地域別、種類・用途別 The Enterobacteriaceae Infection Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tra…